Giant Food Stores to roll out robot Marty across its US grocery stores

Giant Food Stores to roll out robot Marty across its US grocery stores

Date: 2019-01-18 By Ojaswita Kutepatil

Giant Food Stores has recently announced that it would be introducing Marty, a robot, to its 172 stores across the U.S. Apparently, the main purpose of Marty is to autonomously roam around the store and point out hazards for store staff to ....

Patient Handling Equipment Market - By Witness Growth Acceleration During 2018-2024

The plasma proteins or derivatives in blood are extracted via the fractionation process. A range of valuable products are manufactured from blood plasma through fractionation. Fractionation occurs in tanks at near freezing temperatures. F....

Anteo Diagnostics & Sona Nanotech team up to improve lateral flow tests

* The collaboration aims to help accelerate the development & enhance lateral flow immunoassays’ performance. * Under the collaboration agreement, Sona’s gold nanorod tech would be merged with Anteo’s AnteoBind and se....

Alibaba empowers retail digitization with AI-based Hema stores

Alibaba empowers retail digitization with AI-based Hema stores The Alibaba owned offline supermarket Hema was recently put up on exhibit in 2019 Retail's Big Show in New York City, highlighting artificial intelligence and the online co....

BlinQ to introduce luxury e-commerce in the South-East Asian market

Bob Chua, a leading entrepreneur, has recently announced the launch of his latest venture BlinQ, aimed at Asia’s growing luxury fashion e-commerce platform. Apparently, following an IPO (Initial Public Offering) on the LSE (London Sto....

Johnson & Johnson increases US prices on two-dozen prescription drugs

* The company becomes the latest in a list of several other companies to increase the US prices on its drugs. * The move comes on the same day Democratic Congress members proposed a bill that aims to lower prescription drug prices for Amer....

Amazon holds invitation-only meetings with sellers at CES 2019

Amazon is reportedly conducting private meeting with its marketplace sellers at CES 2019 to promote a new premium support service that costs between $30,000 to $60,000 a year. As per trusted sources, the meetings were organized by the e-co....

Pfizer to cease operation at two plants in Maharashtra & Tamil Nadu

In what may seem to be a response against failing product demand, the U.S. drug manufacturer Pfizer announced that it will be closing its two manufacturing plants in India. The plants, reportedly, manufactured generic injectable such as the....

Zydus Cadila granted approval from US FDA to market antipsychotic drug

Indian pharmaceutical firm Zydus Cadila has recently announced that the company has received final approval from the health regulator of the U.S. for marketing Aripiprazole tablets, an antipsychotic drug. The company said in a BS....

Sanofi to pay $462m to Regeneron in a revised immuno-oncology deal

The Paris-based multinational pharmaceutical firm, Sanofi S.A., would pay approximately $462 million to Regeneron, a New York-based biotech firm. Apparently, this move is the result of a revision of their deal in immuno-oncology, a booming ....

Samsung Bioepis-3SBio deal to aid China biosimilar business expansion

In a recent turn of events, Samsung Bioepis Co. has reportedly announced the expansion of its rapidly growing biosimilar business into China via a licensing agreement with 3SBio Inc. As per trusted sources, the agreement encloses Samsung Bi....

Otsuka-Click alliance on digital therapeutics to help MDD patients

Otsuka America, Inc., and Click Therapeutics, Inc., have reportedly announced that they have signed an agreement to develop and commercialize a digital therapeutic for the treatment of MDD. The partnership aims to provide medical assistance....

Roche’s debut immunotherapy may gain approval post positive trials

The Swiss drugmaker Roche on Monday revealed that the trials of their immunotherapy mixture, consisting of Tecentriq combined with chemotherapy, showed positive survival results. Roche hopes that this immunotherapy mixture will be the first....